Vaccinex Inc (VCNX)
5.537
-0.09
(-1.57%)
USD |
NASDAQ |
May 16, 16:00
5.30
-0.24
(-4.27%)
After-Hours: 20:00
Vaccinex Shareholders Equity (Quarterly): -2.311M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.311M |
| September 30, 2023 | -3.869M |
| June 30, 2023 | -0.423M |
| March 31, 2023 | 2.40M |
| December 31, 2022 | 5.193M |
| September 30, 2022 | 6.318M |
| June 30, 2022 | 10.94M |
| March 31, 2022 | 16.19M |
| December 31, 2021 | 7.412M |
| September 30, 2021 | 11.89M |
| June 30, 2021 | 16.94M |
| March 31, 2021 | 0.818M |
| December 31, 2020 | -26.58M |
| Date | Value |
|---|---|
| September 30, 2020 | -20.20M |
| June 30, 2020 | -29.54M |
| March 31, 2020 | -25.70M |
| December 31, 2019 | -26.24M |
| September 30, 2019 | -20.05M |
| June 30, 2019 | -26.34M |
| March 31, 2019 | -17.63M |
| December 31, 2018 | -8.621M |
| September 30, 2018 | -0.218M |
| June 30, 2018 | -28.11M |
| March 31, 2018 | -21.56M |
| December 31, 2017 | -13.74M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-29.54M
Minimum
Jun 2020
16.94M
Maximum
Jun 2021
-5.429M
Average
-0.423M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 663.90M |
| Avinger Inc | -6.202M |
| RAPT Therapeutics Inc | 130.84M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | -11.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.631M |
| Total Liabilities (Quarterly) | 5.942M |